Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -712 | -455 | -245 | -3,425 | -3,089 |
| Depreciation Amortization | 3 | 2 | 1 | 4 | 3 |
| Accounts payable and accrued liabilities | 15 | N/A | N/A | N/A | 323 |
| Other Working Capital | 196 | 105 | 70 | 2,933 | 3,007 |
| Other Operating Activity | 498 | 348 | 174 | 195 | -323 |
| Operating Cash Flow | $N/A | $0 | $0 | $-293 | $-79 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,208 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 215 | 0 |
| Financing Cash Flow | $6,208 | $N/A | $N/A | $215 | $N/A |
| Beginning Cash Position | 7 | 7 | 7 | 85 | 85 |
| End Cash Position | 6,214 | 7 | 7 | 7 | 6 |
| Net Cash Flow | $6,208 | $0 | $0 | $-78 | $-79 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 0 | 0 | -293 | -79 |
| Free Cash Flow | 0 | 0 | 0 | -293 | -79 |